Fresenius Medical Care stock traded at EUR 56.6 per share at the end 2018 translating into a market capitalization of USD 19,901 mil.
Since the end of 2013, stock has appreciated by 10.5% representing an annual average growth of 2.01%. In absolute terms, the value of the company fell by USD 1 mil.
At the end of 2018, the firm traded at price to earnings of 8.77x. Over the last five years, this multiple achieved a high of 25.6x in 2015 and a low of 8.77x in 2018 with an average of 20.2x.
In terms of EV/EBITDA, stock traded at 7.73x at the end of 2018. Since 2013, stock has traded between 7.73x and 12.2x with an average of 10.4x.
You can see all the company’s data at Fresenius Medical Care profile, or you can download a report on the company in the report section.
Helgi Library 
